+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Sale

Global ePharmacy Market by Product (Cold & Flu, Dental, Skin Care), Drug Type (Over the Counter (OTC) Drugs, Prescription Drugs), Type, Business model - Forecast 2024-2030

  • PDF Icon

    Report

  • 180 Pages
  • March 2024
  • Region: Global
  • 360iResearch™
  • ID: 5666330
UP TO OFF until Dec 31st 2024
1h Free Analyst Time
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The ePharmacy Market size was estimated at USD 53.62 billion in 2023, USD 62.65 billion in 2024, and is expected to grow at a CAGR of 17.29% to reach USD 163.84 billion by 2030.

ePharmacy offers easier access to medicine purchases that significantly benefit elderly patients from nuclear families and patients not able to go out. The expansion of the healthcare sector, with increasing operational costs, has created the need to cut operating costs by implementing ePharmacy solutions. The ePharmacy model is simple to use and has replaced traditional pharmacies, including medical services, and experienced an increase in site traffic and sales due to the COVID-19 pandemic. The continuous adoption of digital technologies in the healthcare sector for better accessibility and flexibility and the growing geriatric population with chronic and acute conditions across the globe increases the adoption of ePharmacy worldwide. However, the requirement of technical expertise and adequate infrastructure for ePharmacy development and issues about patient data privacy & security due to the emergence of hacking and fishing activities is significantly impeding the adoption of ePharmacy. In addition, companies focus on deploying artificial intelligence (AI) and blockchain technology and introducing virtual assistance in ePharmacy to provide great convenience and offer a wider range of options than a traditional pharmacy.

Regional Insights

The rising adoption of eCommerce, growing geriatric population, increasing online sales, developed healthcare infrastructure, and positive attitude towards adopting new technologies are expanding the utilization of ePharmacy in the United States. Approximately 80% of the population of the U.S. is connected to ePharmacy, and the trend is shifting toward the direct-to-patient model. High caseloads in the United States and regional lockdowns have pushed consumers to adopt the ePharmacy platforms to order medicines online from the comfort of their homes rather than visiting offline pharmacies and diagnostic centers. Emerging economies, such as China and India, possess high growth potential owing to the large population base coupled with increasing government initiatives supporting the adoption of digital technologies. In the UK and Germany, the utilization of ePharmacy is growing significantly due to the rise in inclination toward the online mode of medicine purchase among the people. According to the survey for the General Pharmaceutical Council (2021), 25% of people in the UK are expected to use an online pharmacy in the future. Doctors prefer ePrescriptions for patients to access medicine with the help of ePrescriptions quickly.

FPNV Positioning Matrix

The FPNV Positioning Matrix is pivotal in evaluating the ePharmacy Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the ePharmacy Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Key Company Profiles

The report delves into recent significant developments in the ePharmacy Market, highlighting leading vendors and their innovative profiles. These include Amazon.com, Inc., Apex Healthcare Berhad, Apollo Pharmacies Ltd., Aster Pharmacies Group LLC, BinSina Pharmacy, CareOnGo, Chemist Direct, CVS Health Corporation, De Online Drogist, DOCIB Group, Euro-pharmas, Express Scripts Holding Company by Cigna, Farmacia Internacional, HealthPlus Pharmacy, Healthxchange Pharmacy UK Ltd., Life Pharmacy, LloydsPharmacy Ltd., Lékárna WPK SRO, Mahendra ePharmacy Pvt. Ltd., mChemist Global Pvt. Ltd., Medexpresspharma by Life Wind Medicare Pvt. Ltd., Medicina Pharmacy, MonCoinSanté, myPOS Software Solutions (Pvt) Ltd., Netmeds by Reliance Retail Ltd., Newpharma by Colruyt Group, OneHealth Nigeria, OptumRx, Inc., Oxford e-Pharmacy, Parafarmacia-online, Pharm24.gr, Pharmacynet, Pharmeasy by Axelia Solutions Pvt. Ltd., Practo Technologies Pvt. Ltd., Rowlands Pharmacy by Phoenix Group, Shop Apotheke Europe N.V., Tata 1mg, The French Pharmacy, The Independent Pharmacy, The Kroger Co., UK Meds Direct Ltd., Vamida s.r.o., Walgreen Co., Walmart Inc., Wockhardtepharmacy, and Zur Rose Group AG.

Market Segmentation & Coverage

This research report categorizes the ePharmacy Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Product
    • Cold & Flu
    • Dental
    • Skin Care
    • Vitamins
    • Weight Loss
  • Drug Type
    • Over the Counter (OTC) Drugs
    • Prescription Drugs
  • Type
    • Integrated
    • Standalone
  • Business model
    • Direct
    • Marketplace
    • Pharmacy
  • Region
    • Americas
      • Argentina
      • Brazil
      • Canada
      • Mexico
      • United States
        • California
        • Florida
        • Illinois
        • New York
        • Ohio
        • Pennsylvania
        • Texas
    • Asia-Pacific
      • Australia
      • China
      • India
      • Indonesia
      • Japan
      • Malaysia
      • Philippines
      • Singapore
      • South Korea
      • Taiwan
      • Thailand
      • Vietnam
    • Europe, Middle East & Africa
      • Denmark
      • Egypt
      • Finland
      • France
      • Germany
      • Israel
      • Italy
      • Netherlands
      • Nigeria
      • Norway
      • Poland
      • Qatar
      • Russia
      • Saudi Arabia
      • South Africa
      • Spain
      • Sweden
      • Switzerland
      • Turkey
      • United Arab Emirates
      • United Kingdom

The report offers valuable insights on the following aspects:

  1. Market Penetration: It presents comprehensive information on the market provided by key players.
  2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.
  3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.
  4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.
  5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as:

  1. What is the market size and forecast of the ePharmacy Market?
  2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the ePharmacy Market?
  3. What are the technology trends and regulatory frameworks in the ePharmacy Market?
  4. What is the market share of the leading vendors in the ePharmacy Market?
  5. Which modes and strategic moves are suitable for entering the ePharmacy Market?

Please note: For this report, the purchase of an Enterprise license allows up to ten worldwide users of an organization access to the report

Please note: This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

With the purchase of this report at the Multi-user License or greater level, you will have access to one hour with an expert analyst who will help you link key findings in the report to the business issues you're addressing. This will need to be used within three months of purchase.

This report also includes a complimentary Excel file with data from the report for purchasers at the Site License or greater level.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. ePharmacy Market, by Region
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Rapid adoption of digital technologies and eCommerce in healthcare sector for better accessibility and flexibility
5.1.1.2. Evolution of teleconsultation across the globe leads the adoption of ePharmacy facilities
5.1.1.3. Growing geriatric population with chronic and acute conditions across the globe
5.1.2. Restraints
5.1.2.1. Requirement of technical expertise and adequate infrastructure for ePharmacy development
5.1.3. Opportunities
5.1.3.1. Deployment of artificial intelligence and blockchain technology in ePharmacy
5.1.3.2. Introduction of virtual assistance in ePharmacy
5.1.4. Challenges
5.1.4.1. Concern regarding inappropriate labeling of drugs in ePharmacy
5.1.4.2. Issues pertaining to patient’s data privacy and security due to emergence of hacking and fishing activities
5.2. Market Segmentation Analysis
5.3. Market Trend Analysis
5.4. Cumulative Impact of High Inflation
5.5. Porter’s Five Forces Analysis
5.5.1. Threat of New Entrants
5.5.2. Threat of Substitutes
5.5.3. Bargaining Power of Customers
5.5.4. Bargaining Power of Suppliers
5.5.5. Industry Rivalry
5.6. Value Chain & Critical Path Analysis
5.7. Regulatory Framework
6. ePharmacy Market, by Product
6.1. Introduction
6.2. Cold & Flu
6.3. Dental
6.4. Skin Care
6.5. Vitamins
6.6. Weight Loss
7. ePharmacy Market, by Drug Type
7.1. Introduction
7.2. Over the Counter (OTC) Drugs
7.3. Prescription Drugs
8. ePharmacy Market, by Type
8.1. Introduction
8.2. Integrated
8.3. Standalone
9. ePharmacy Market, by Business model
9.1. Introduction
9.2. Direct
9.3. Marketplace
9.4. Pharmacy
10. Americas ePharmacy Market
10.1. Introduction
10.2. Argentina
10.3. Brazil
10.4. Canada
10.5. Mexico
10.6. United States
11. Asia-Pacific ePharmacy Market
11.1. Introduction
11.2. Australia
11.3. China
11.4. India
11.5. Indonesia
11.6. Japan
11.7. Malaysia
11.8. Philippines
11.9. Singapore
11.10. South Korea
11.11. Taiwan
11.12. Thailand
11.13. Vietnam
12. Europe, Middle East & Africa ePharmacy Market
12.1. Introduction
12.2. Denmark
12.3. Egypt
12.4. Finland
12.5. France
12.6. Germany
12.7. Israel
12.8. Italy
12.9. Netherlands
12.10. Nigeria
12.11. Norway
12.12. Poland
12.13. Qatar
12.14. Russia
12.15. Saudi Arabia
12.16. South Africa
12.17. Spain
12.18. Sweden
12.19. Switzerland
12.20. Turkey
12.21. United Arab Emirates
12.22. United Kingdom
13. Competitive Landscape
13.1. FPNV Positioning Matrix
13.2. Market Share Analysis, By Key Player
13.3. Competitive Scenario Analysis, By Key Player
13.3.1. Merger & Acquisition
13.3.1.1. Flipkart In Discussions To Acquire Online Pharmacy Pharmallama
13.3.2. New Product Launch & Enhancement
13.3.2.1. Med-Direct Africa Launches e-Pharmacy, Promises Price Reduction.
13.3.2.2. Flipkart taps healthcare sector with brand new 'Flipkart Health+' app.
13.3.3. Investment & Funding
13.3.3.1. Vietnamese e-pharmacy Medigo raises $2M and more digital health fundings.
13.3.3.2. e-pharmacy Grinta raises US$8 mln to develop its tech platform.
13.3.3.3. Tata 1mg raises $40 mn led by Tata Digital, becomes unicorn.
13.3.3.4. Kenyan e-pharmacy startup MYDAWA banks $1.2m grant funding from Gates.
13.3.3.5. PharmEasy Raises $350 Mn; Becomes India's First Epharmacy Unicorn.
13.3.4. Award, Recognition, & Expansion
13.3.4.1. US startup launches e-pharmacy platform in Myanmar.
13.3.4.2. Med-Direct Africa launches e-Pharmacy in Nigeria.
14. Competitive Portfolio
14.1. Key Company Profiles
14.1.1. Amazon.com, Inc.
14.1.2. Apex Healthcare Berhad
14.1.3. Apollo Pharmacies Ltd.
14.1.4. Aster Pharmacies Group LLC
14.1.5. BinSina Pharmacy
14.1.6. CareOnGo
14.1.7. Chemist Direct
14.1.8. CVS Health Corporation
14.1.9. De Online Drogist
14.1.10. DOCIB Group
14.1.11. Euro-pharmas
14.1.12. Express Scripts Holding Company by Cigna
14.1.13. Farmacia Internacional
14.1.14. HealthPlus Pharmacy
14.1.15. Healthxchange Pharmacy UK Ltd.
14.1.16. Life Pharmacy
14.1.17. LloydsPharmacy Ltd.
14.1.18. Lékárna WPK SRO
14.1.19. Mahendra ePharmacy Pvt. Ltd.
14.1.20. mChemist Global Pvt. Ltd.
14.1.21. Medexpresspharma by Life Wind Medicare Pvt. Ltd.
14.1.22. Medicina Pharmacy
14.1.23. MonCoinSanté
14.1.24. myPOS Software Solutions (Pvt) Ltd.
14.1.25. Netmeds by Reliance Retail Ltd.
14.1.26. Newpharma by Colruyt Group
14.1.27. OneHealth Nigeria
14.1.28. OptumRx, Inc.
14.1.29. Oxford e-Pharmacy
14.1.30. Parafarmacia-online
14.1.31. Pharm24.gr
14.1.32. Pharmacynet
14.1.33. Pharmeasy by Axelia Solutions Pvt. Ltd.
14.1.34. Practo Technologies Pvt. Ltd.
14.1.35. Rowlands Pharmacy by Phoenix Group
14.1.36. Shop Apotheke Europe N.V.
14.1.37. Tata 1mg
14.1.38. The French Pharmacy
14.1.39. The Independent Pharmacy
14.1.40. The Kroger Co.
14.1.41. UK Meds Direct Ltd.
14.1.42. Vamida s.r.o.
14.1.43. Walgreen Co.
14.1.44. Walmart Inc.
14.1.45. Wockhardtepharmacy
14.1.46. Zur Rose Group AG
14.2. Key Product Portfolio
15. Appendix
15.1. Discussion Guide
15.2. License & Pricing
List of Figures
FIGURE 1. EPHARMACY MARKET RESEARCH PROCESS
FIGURE 2. EPHARMACY MARKET SIZE, 2023 VS 2030
FIGURE 3. EPHARMACY MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 4. EPHARMACY MARKET SIZE, BY REGION, 2023 VS 2030 (%)
FIGURE 5. EPHARMACY MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 6. EPHARMACY MARKET DYNAMICS
FIGURE 7. EPHARMACY MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
FIGURE 8. EPHARMACY MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 9. EPHARMACY MARKET SIZE, BY DRUG TYPE, 2023 VS 2030 (%)
FIGURE 10. EPHARMACY MARKET SIZE, BY DRUG TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 11. EPHARMACY MARKET SIZE, BY TYPE, 2023 VS 2030 (%)
FIGURE 12. EPHARMACY MARKET SIZE, BY TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 13. EPHARMACY MARKET SIZE, BY BUSINESS MODEL, 2023 VS 2030 (%)
FIGURE 14. EPHARMACY MARKET SIZE, BY BUSINESS MODEL, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 15. AMERICAS EPHARMACY MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 16. AMERICAS EPHARMACY MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 17. UNITED STATES EPHARMACY MARKET SIZE, BY STATE, 2023 VS 2030 (%)
FIGURE 18. UNITED STATES EPHARMACY MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 19. ASIA-PACIFIC EPHARMACY MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 20. ASIA-PACIFIC EPHARMACY MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 21. EUROPE, MIDDLE EAST & AFRICA EPHARMACY MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 22. EUROPE, MIDDLE EAST & AFRICA EPHARMACY MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 23. EPHARMACY MARKET, FPNV POSITIONING MATRIX, 2023
FIGURE 24. EPHARMACY MARKET SHARE, BY KEY PLAYER, 2023
List of Tables
TABLE 1. EPHARMACY MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
TABLE 3. EPHARMACY MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL EPHARMACY MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. EPHARMACY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 6. EPHARMACY MARKET SIZE, BY COLD & FLU, BY REGION, 2018-2030 (USD MILLION)
TABLE 7. EPHARMACY MARKET SIZE, BY DENTAL, BY REGION, 2018-2030 (USD MILLION)
TABLE 8. EPHARMACY MARKET SIZE, BY SKIN CARE, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. EPHARMACY MARKET SIZE, BY VITAMINS, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. EPHARMACY MARKET SIZE, BY WEIGHT LOSS, BY REGION, 2018-2030 (USD MILLION)
TABLE 11. EPHARMACY MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 12. EPHARMACY MARKET SIZE, BY OVER THE COUNTER (OTC) DRUGS, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. EPHARMACY MARKET SIZE, BY PRESCRIPTION DRUGS, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. EPHARMACY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 15. EPHARMACY MARKET SIZE, BY INTEGRATED, BY REGION, 2018-2030 (USD MILLION)
TABLE 16. EPHARMACY MARKET SIZE, BY STANDALONE, BY REGION, 2018-2030 (USD MILLION)
TABLE 17. EPHARMACY MARKET SIZE, BY BUSINESS MODEL, 2018-2030 (USD MILLION)
TABLE 18. EPHARMACY MARKET SIZE, BY DIRECT, BY REGION, 2018-2030 (USD MILLION)
TABLE 19. EPHARMACY MARKET SIZE, BY MARKETPLACE, BY REGION, 2018-2030 (USD MILLION)
TABLE 20. EPHARMACY MARKET SIZE, BY PHARMACY, BY REGION, 2018-2030 (USD MILLION)
TABLE 21. AMERICAS EPHARMACY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 22. AMERICAS EPHARMACY MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 23. AMERICAS EPHARMACY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 24. AMERICAS EPHARMACY MARKET SIZE, BY BUSINESS MODEL, 2018-2030 (USD MILLION)
TABLE 25. AMERICAS EPHARMACY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 26. ARGENTINA EPHARMACY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 27. ARGENTINA EPHARMACY MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 28. ARGENTINA EPHARMACY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 29. ARGENTINA EPHARMACY MARKET SIZE, BY BUSINESS MODEL, 2018-2030 (USD MILLION)
TABLE 30. BRAZIL EPHARMACY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 31. BRAZIL EPHARMACY MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 32. BRAZIL EPHARMACY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 33. BRAZIL EPHARMACY MARKET SIZE, BY BUSINESS MODEL, 2018-2030 (USD MILLION)
TABLE 34. CANADA EPHARMACY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 35. CANADA EPHARMACY MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 36. CANADA EPHARMACY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 37. CANADA EPHARMACY MARKET SIZE, BY BUSINESS MODEL, 2018-2030 (USD MILLION)
TABLE 38. MEXICO EPHARMACY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 39. MEXICO EPHARMACY MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 40. MEXICO EPHARMACY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 41. MEXICO EPHARMACY MARKET SIZE, BY BUSINESS MODEL, 2018-2030 (USD MILLION)
TABLE 42. UNITED STATES EPHARMACY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 43. UNITED STATES EPHARMACY MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 44. UNITED STATES EPHARMACY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 45. UNITED STATES EPHARMACY MARKET SIZE, BY BUSINESS MODEL, 2018-2030 (USD MILLION)
TABLE 46. UNITED STATES EPHARMACY MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 47. ASIA-PACIFIC EPHARMACY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 48. ASIA-PACIFIC EPHARMACY MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 49. ASIA-PACIFIC EPHARMACY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 50. ASIA-PACIFIC EPHARMACY MARKET SIZE, BY BUSINESS MODEL, 2018-2030 (USD MILLION)
TABLE 51. ASIA-PACIFIC EPHARMACY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 52. AUSTRALIA EPHARMACY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 53. AUSTRALIA EPHARMACY MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 54. AUSTRALIA EPHARMACY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 55. AUSTRALIA EPHARMACY MARKET SIZE, BY BUSINESS MODEL, 2018-2030 (USD MILLION)
TABLE 56. CHINA EPHARMACY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 57. CHINA EPHARMACY MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 58. CHINA EPHARMACY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 59. CHINA EPHARMACY MARKET SIZE, BY BUSINESS MODEL, 2018-2030 (USD MILLION)
TABLE 60. INDIA EPHARMACY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 61. INDIA EPHARMACY MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 62. INDIA EPHARMACY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 63. INDIA EPHARMACY MARKET SIZE, BY BUSINESS MODEL, 2018-2030 (USD MILLION)
TABLE 64. INDONESIA EPHARMACY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 65. INDONESIA EPHARMACY MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 66. INDONESIA EPHARMACY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 67. INDONESIA EPHARMACY MARKET SIZE, BY BUSINESS MODEL, 2018-2030 (USD MILLION)
TABLE 68. JAPAN EPHARMACY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 69. JAPAN EPHARMACY MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 70. JAPAN EPHARMACY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 71. JAPAN EPHARMACY MARKET SIZE, BY BUSINESS MODEL, 2018-2030 (USD MILLION)
TABLE 72. MALAYSIA EPHARMACY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 73. MALAYSIA EPHARMACY MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 74. MALAYSIA EPHARMACY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 75. MALAYSIA EPHARMACY MARKET SIZE, BY BUSINESS MODEL, 2018-2030 (USD MILLION)
TABLE 76. PHILIPPINES EPHARMACY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 77. PHILIPPINES EPHARMACY MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 78. PHILIPPINES EPHARMACY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 79. PHILIPPINES EPHARMACY MARKET SIZE, BY BUSINESS MODEL, 2018-2030 (USD MILLION)
TABLE 80. SINGAPORE EPHARMACY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 81. SINGAPORE EPHARMACY MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 82. SINGAPORE EPHARMACY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 83. SINGAPORE EPHARMACY MARKET SIZE, BY BUSINESS MODEL, 2018-2030 (USD MILLION)
TABLE 84. SOUTH KOREA EPHARMACY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 85. SOUTH KOREA EPHARMACY MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 86. SOUTH KOREA EPHARMACY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 87. SOUTH KOREA EPHARMACY MARKET SIZE, BY BUSINESS MODEL, 2018-2030 (USD MILLION)
TABLE 88. TAIWAN EPHARMACY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 89. TAIWAN EPHARMACY MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 90. TAIWAN EPHARMACY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 91. TAIWAN EPHARMACY MARKET SIZE, BY BUSINESS MODEL, 2018-2030 (USD MILLION)
TABLE 92. THAILAND EPHARMACY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 93. THAILAND EPHARMACY MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 94. THAILAND EPHARMACY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 95. THAILAND EPHARMACY MARKET SIZE, BY BUSINESS MODEL, 2018-2030 (USD MILLION)
TABLE 96. VIETNAM EPHARMACY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 97. VIETNAM EPHARMACY MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 98. VIETNAM EPHARMACY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 99. VIETNAM EPHARMACY MARKET SIZE, BY BUSINESS MODEL, 2018-2030 (USD MILLION)
TABLE 100. EUROPE, MIDDLE EAST & AFRICA EPHARMACY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 101. EUROPE, MIDDLE EAST & AFRICA EPHARMACY MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 102. EUROPE, MIDDLE EAST & AFRICA EPHARMACY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 103. EUROPE, MIDDLE EAST & AFRICA EPHARMACY MARKET SIZE, BY BUSINESS MODEL, 2018-2030 (USD MILLION)
TABLE 104. EUROPE, MIDDLE EAST & AFRICA EPHARMACY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 105. DENMARK EPHARMACY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 106. DENMARK EPHARMACY MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 107. DENMARK EPHARMACY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 108. DENMARK EPHARMACY MARKET SIZE, BY BUSINESS MODEL, 2018-2030 (USD MILLION)
TABLE 109. EGYPT EPHARMACY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 110. EGYPT EPHARMACY MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 111. EGYPT EPHARMACY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 112. EGYPT EPHARMACY MARKET SIZE, BY BUSINESS MODEL, 2018-2030 (USD MILLION)
TABLE 113. FINLAND EPHARMACY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 114. FINLAND EPHARMACY MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 115. FINLAND EPHARMACY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 116. FINLAND EPHARMACY MARKET SIZE, BY BUSINESS MODEL, 2018-2030 (USD MILLION)
TABLE 117. FRANCE EPHARMACY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 118. FRANCE EPHARMACY MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 119. FRANCE EPHARMACY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 120. FRANCE EPHARMACY MARKET SIZE, BY BUSINESS MODEL, 2018-2030 (USD MILLION)
TABLE 121. GERMANY EPHARMACY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 122. GERMANY EPHARMACY MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 123. GERMANY EPHARMACY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 124. GERMANY EPHARMACY MARKET SIZE, BY BUSINESS MODEL, 2018-2030 (USD MILLION)
TABLE 125. ISRAEL EPHARMACY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 126. ISRAEL EPHARMACY MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 127. ISRAEL EPHARMACY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 128. ISRAEL EPHARMACY MARKET SIZE, BY BUSINESS MODEL, 2018-2030 (USD MILLION)
TABLE 129. ITALY EPHARMACY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 130. ITALY EPHARMACY MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 131. ITALY EPHARMACY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 132. ITALY EPHARMACY MARKET SIZE, BY BUSINESS MODEL, 2018-2030 (USD MILLION)
TABLE 133. NETHERLANDS EPHARMACY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 134. NETHERLANDS EPHARMACY MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 135. NETHERLANDS EPHARMACY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 136. NETHERLANDS EPHARMACY MARKET SIZE, BY BUSINESS MODEL, 2018-2030 (USD MILLION)
TABLE 137. NIGERIA EPHARMACY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 138. NIGERIA EPHARMACY MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 139. NIGERIA EPHARMACY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 140. NIGERIA EPHARMACY MARKET SIZE, BY BUSINESS MODEL, 2018-2030 (USD MILLION)
TABLE 141. NORWAY EPHARMACY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 142. NORWAY EPHARMACY MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 143. NORWAY EPHARMACY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 144. NORWAY EPHARMACY MARKET SIZE, BY BUSINESS MODEL, 2018-2030 (USD MILLION)
TABLE 145. POLAND EPHARMACY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 146. POLAND EPHARMACY MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 147. POLAND EPHARMACY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 148. POLAND EPHARMACY MARKET SIZE, BY BUSINESS MODEL, 2018-2030 (USD MILLION)
TABLE 149. QATAR EPHARMACY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 150. QATAR EPHARMACY MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 151. QATAR EPHARMACY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 152. QATAR EPHARMACY MARKET SIZE, BY BUSINESS MODEL, 2018-2030 (USD MILLION)
TABLE 153. RUSSIA EPHARMACY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 154. RUSSIA EPHARMACY MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 155. RUSSIA EPHARMACY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 156. RUSSIA EPHARMACY MARKET SIZE, BY BUSINESS MODEL, 2018-2030 (USD MILLION)
TABLE 157. SAUDI ARABIA EPHARMACY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 158. SAUDI ARABIA EPHARMACY MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 159. SAUDI ARABIA EPHARMACY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 160. SAUDI ARABIA EPHARMACY MARKET SIZE, BY BUSINESS MODEL, 2018-2030 (USD MILLION)
TABLE 161. SOUTH AFRICA EPHARMACY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 162. SOUTH AFRICA EPHARMACY MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 163. SOUTH AFRICA EPHARMACY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 164. SOUTH AFRICA EPHARMACY MARKET SIZE, BY BUSINESS MODEL, 2018-2030 (USD MILLION)
TABLE 165. SPAIN EPHARMACY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 166. SPAIN EPHARMACY MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 167. SPAIN EPHARMACY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 168. SPAIN EPHARMACY MARKET SIZE, BY BUSINESS MODEL, 2018-2030 (USD MILLION)
TABLE 169. SWEDEN EPHARMACY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 170. SWEDEN EPHARMACY MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 171. SWEDEN EPHARMACY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 172. SWEDEN EPHARMACY MARKET SIZE, BY BUSINESS MODEL, 2018-2030 (USD MILLION)
TABLE 173. SWITZERLAND EPHARMACY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 174. SWITZERLAND EPHARMACY MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 175. SWITZERLAND EPHARMACY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 176. SWITZERLAND EPHARMACY MARKET SIZE, BY BUSINESS MODEL, 2018-2030 (USD MILLION)
TABLE 177. TURKEY EPHARMACY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 178. TURKEY EPHARMACY MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 179. TURKEY EPHARMACY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 180. TURKEY EPHARMACY MARKET SIZE, BY BUSINESS MODEL, 2018-2030 (USD MILLION)
TABLE 181. UNITED ARAB EMIRATES EPHARMACY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 182. UNITED ARAB EMIRATES EPHARMACY MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 183. UNITED ARAB EMIRATES EPHARMACY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 184. UNITED ARAB EMIRATES EPHARMACY MARKET SIZE, BY BUSINESS MODEL, 2018-2030 (USD MILLION)
TABLE 185. UNITED KINGDOM EPHARMACY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 186. UNITED KINGDOM EPHARMACY MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 187. UNITED KINGDOM EPHARMACY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 188. UNITED KINGDOM EPHARMACY MARKET SIZE, BY BUSINESS MODEL, 2018-2030 (USD MILLION)
TABLE 189. EPHARMACY MARKET, FPNV POSITIONING MATRIX, 2023
TABLE 190. EPHARMACY MARKET SHARE, BY KEY PLAYER, 2023
TABLE 191. EPHARMACY MARKET LICENSE & PRICING

Companies Mentioned

  • Amazon.com, Inc.
  • Apex Healthcare Berhad
  • Apollo Pharmacies Ltd.
  • Aster Pharmacies Group LLC
  • BinSina Pharmacy
  • CareOnGo
  • Chemist Direct
  • CVS Health Corporation
  • De Online Drogist
  • DOCIB Group
  • Euro-pharmas
  • Express Scripts Holding Company by Cigna
  • Farmacia Internacional
  • HealthPlus Pharmacy
  • Healthxchange Pharmacy UK Ltd.
  • Life Pharmacy
  • LloydsPharmacy Ltd.
  • Lékárna WPK SRO
  • Mahendra ePharmacy Pvt. Ltd.
  • mChemist Global Pvt. Ltd.
  • Medexpresspharma by Life Wind Medicare Pvt. Ltd.
  • Medicina Pharmacy
  • MonCoinSanté
  • myPOS Software Solutions (Pvt) Ltd.
  • Netmeds by Reliance Retail Ltd.
  • Newpharma by Colruyt Group
  • OneHealth Nigeria
  • OptumRx, Inc.
  • Oxford e-Pharmacy
  • Parafarmacia-online
  • Pharm24.gr
  • Pharmacynet
  • Pharmeasy by Axelia Solutions Pvt. Ltd.
  • Practo Technologies Pvt. Ltd.
  • Rowlands Pharmacy by Phoenix Group
  • Shop Apotheke Europe N.V.
  • Tata 1mg
  • The French Pharmacy
  • The Independent Pharmacy
  • The Kroger Co.
  • UK Meds Direct Ltd.
  • Vamida s.r.o.
  • Walgreen Co.
  • Walmart Inc.
  • Wockhardtepharmacy
  • Zur Rose Group AG

Methodology

Loading
LOADING...

Table Information